Navigation Links
Lumalier Partners with Philips Healthcare to Provide Tru-D Solution for Reduction of Environmental Pathogens in Healthcare Facilities
Date:7/14/2011

MEMPHIS, Tenn., July 14, 2011 /PRNewswire/ -- Lumalier Corporation announces an agreement with Philips Healthcare to address the growing problem of microbial contamination in hospitals. The distribution agreement was announced at the annual conference of the Association for Professionals in Infection Control and Hospital Epidemiology (APIC), where representatives from Philips Healthcare joined Lumalier consultants to showcase the Tru-D total-room ultraviolet (UV) disinfector.

Tru-D is an automated, no-touch, portable UV device that helps control pathogens known to contaminate environmental surfaces. Thorough environmental cleaning is at the forefront at a time when healthcare-acquired infections (HAIs) are the most common complication of hospital care and one of the top ten leading causes of death in the United States.

"Manual cleaning can be fraught with human error -- especially in hard-to-reach places," says Jeffrey Stephens, MD, professor of medicine and infectious diseases at Mercer University School of Medicine, Medical Center of Central Georgia. "The Tru-D Sensor360™ technology measures the reflected dose of UV light to reduce pathogens on visible surfaces, in primary shadows, behind and below bed rails, trays, doorknobs, IV poles and portable equipment." Scientific data provided by published, peer-reviewed studies indicate that no UV Room Disinfection System other than Tru-D can substantiate these high-level disinfection claims (1,2,3).

Environmental cleaning was the focus of several presentations at the APIC conference. Dr. William Rutala, PhD, MPH, Professor of Infectious Diseases at the University of North Carolina's School of Medicine, reviewed issues associated with environmental hygiene and room decontamination and presented Tru-D as an emerging automated disinfection technology.

In a separate presentation, Ann Marie Pettis, RN, BSN, CIC, Director of Infection Prevention at University of Rochester Medical Center, described how innovative Tru-D technology is being used to significantly reduce Clostridium difficile spores in clinical patient care areas, nursing units and operating rooms.

Studies demonstrate that only 48 percent of hospital environmental surfaces are cleaned at terminal room cleaning. "Tru-D is a simple option to help eliminate pathogens," says William Carroll Thompson, vice president of service for patient monitoring at Philips Healthcare. "As a company dedicated to simplifying healthcare, we are very pleased to bring this innovative solution to our customers and to their patients."

To review published, peer-reviewed Tru-D studies for the environmental elimination of MRSA, Acinetobacter, VRE, C.diff, and other infectious pathogens, visit http://Tru-D.net. For additional information on Tru-D technology or to request an on-site demonstration, please call 800-774-5799 or contact Chuck Dunn @ ChuckDunn@lumalier.com.

1. Nancy Nerandzic; Curtis Donskey, MD, 'Evaluation of an Automated Ultraviolet Radiation Device for Decontamination of Healthcare-Associated pathogens in Hospital Rooms and on Portable Medical Equipment', BMS Infections Diseases 2010, 10:197.

2. William Rutala, PhD, MPH; Maria Gergen MT (ASCP); David J Weber, MD, MPH, 'Room Decontamination with UV Radiation', Infection Control and Hospital Epidemiology, October 2010, Vol 31, No. 10.

3. Vipin K. Rastogi, PhD; Lalena Wallace, MS; Lisa S. Smith, MS, 'Disinfection of Acinetobacter baumannii-Contaminated Surfaces Relevant to Medical Treatment Facilities with Ultraviolet C Light', Military Medicine 2007, 172, 11:1166.

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Lumalier Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
5. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
6. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
7. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
8. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
9. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
10. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
11. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Prima BioMed has presented encouraging early signs ... combination with Keytruda, with one of the six melanoma ... response. Recruitment in the second cohort is complete and ... by Q317. Preliminary efficacy data from the 15-patient, run-in ... mid-year (recruitment in the 226-patient Phase IIb component is ...
(Date:3/23/2017)... , March 23, 2017 ... consolidated vendor landscape with the top five players ... in 2015. These companies are Stryker Sustainability Solutions, ... Health Services, Inc., and VANGUARD AG. Despite the ... devices market is witnessing the prevalence of fierce ...
(Date:3/23/2017)... MUMBAI , March 23, 2017 ... de Piramal Enterprises Limited, anuncia el nombramiento de ... PPS ofrece una plataforma de servicios integrados completa ... Needleman desempeñará un cargo clave en el crecimiento ... comercial, Needleman será responsable de impulsar todas las ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... Texas Physical Therapy Specialists (TexPTS) is ... in Building 2. The clinic is the group’s second in New Braunfels and 22nd ... company’s second New Braunfels location brings things full circle for the group, “It’s crazy ...
(Date:3/23/2017)... ... ... The IoT (Internet of Things) is revolutionizing the way the world operates. ... individual consumers alike. Laboratories can maximize their profit margin by increasing throughput. ... to $11 trillion dollars by the year 2025. McKinsey expects the IoT to have ...
(Date:3/23/2017)... York, NY (PRWEB) , ... March 23, 2017 , ... 82% of adults are unaware ... 3 kids do not brush their teeth the minimum two times a day that dentists ... with students missing 51 million hours of school and adults missing 164 million hours of ...
(Date:3/23/2017)... ... March 23, 2017 , ... March is National Kidney Month – the perfect ... comes to maintaining good health. Every day, two kidneys filter about 120 to 150 ... of your blood, eliminating waste, regulating fluid levels and blood pressure, supporting bone health ...
(Date:3/23/2017)... ... March 23, 2017 , ... The StayWell Company announced ... The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive ... that have excellent programs for the delivery and improvement of disease management and ...
Breaking Medicine News(10 mins):